Revisions for Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Safety and efficacy of VAXIRA® in advanced NSCLC patients not progressing after first line chemotherapy. Phase III. has 2 revisions.

Revision		Status
Saved 19/07/2023 - 3:20pm by Gladys		current revision (published)
Saved 01/10/2020 - 11:50am by Gladys		archived

Registered Trials

Registration process

About the RPCEC

Useful resources